• Academy Backs Senate Bill to Preserve Longstanding Approval Process for Ophthalmic Drugs


    The Academy has helped draft a bill to ensure the continued safe and effective regulation of ophthalmic drugs by addressing a new potentially burdensome FDA rule on combination products.  .